Fall Risk Assessment and an Exercise Intervention for Prevention of Falls in Multiple Myeloma Patients

Recruiting N/A Interventional Study
Multiple Myeloma Fall Risk Factors Strength Training Effects Balance Training Effects
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Prevention
Participants needed
60 (estimated)
Sponsor
University Hospital Heidelberg · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Approximately one third of the population over the age of 65 falls at least once a year. The risk of falling is in increased in older patients with tumor diseases. In addition to high treatment and care costs for the healthcare system, falls often lead to a decrease of quality of life, a reduction in physical performance and a loss of independence. Despite the high risk, falls in cancer patients h…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients with multiple myeloma requiring therapy (at least 6 months of systemic therapy) * ECOG status ≤ 3 * Age ≥18 years * Patients who state that they want to carry out the training program at least 3 times/week and participate in the planned follow-up visits * Ability to g…
Contacts

Ulrike Dapunt, prof. Dr. med

+49 622156 32765

ulrike.dapunt@med.uni-heidelberg.de

CONTACT